Screener
Intellia Therapeutics NTLA Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's net margin?
- Intellia Therapeutics (NTLA) reported net margin of -672.2% in Q2 2026.
- How has Intellia Therapeutics's net margin changed year-over-year?
- Intellia Therapeutics's net margin increased by 26.0% year-over-year, from -908.5% to -672.2%.
- What is the long-term trend for Intellia Therapeutics's net margin?
- Over 5 years (2020 to 2025), Intellia Therapeutics's net margin has grown at a 21.4% compound annual growth rate (CAGR), from -231.5% to -609.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Intellia Therapeutics's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude